共 88 条
- [1] Isaacs A(1957)Virus interference. I. The interferon Proc R Soc 147 258-267
- [2] Lindenmann J(2004)Diagnosis, management and treatment of hepatitis C American association of liver disease Hepatology 39 1147-7
- [3] Strader DB(2008)Understanding the interferon molecule Gastroenterol Hepatol 4 3-210
- [4] Wright T(2004)Thyroid autoimmunity and dysfunction associated with type I interferon therapy Clin Exp Med 3 199-291
- [5] Thomas DL(1996)Side effects of high-dose interferon therapy for chronic hepatitis C J Hepatol 25 283-517
- [6] Seeff LB(1998)Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis J Hepatol 28 514-692
- [7] Jacobson IM(2006)Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C Eur J Gastroenterol Hepatol 18 689-46
- [8] Monzani F(2008)High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection Liver Int 28 39-58
- [9] Caraccio N(2001)Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations Endocr Pract 7 52-173
- [10] Dardano A(2002)Autoimmune disease complicating antiviral therapy for hepatitis C virus infection Semin Arthritis Rheum 32 163-513